CDKN2A Antibody, mAb, Rabbit
CDKN2A Antibody, MAb, Rabbit

All lanes use CDKN2A Antibody, mAb, Rabbit at 1:1K dilution for 1 hour at room temperature.

CDKN2A Antibody, mAb, Rabbit

Acts as a negative regulator of the proliferation of normal cells by interacting strongly with CDK4 and CDK6. This inhibits their ability to interact with cyclins D and to phosphorylate the retinoblastoma protein.
A02751
¥37,309.00

Ask us a question
Overview
Specificity This product is specific to CDKN2A
Host Species Rabbit
Immunogen A synthesized peptide derived from human CDKN2A
Species Reactivity Human
Conjugate Unconjugated

Applications
Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product.
Application Recommended Usage
Western Blot 1:1000-1:2000
Immunohistochemistry (IHC) 1:100-1:200
Immunocytochemistry/Immunofluorescence (ICC/IF) 1:50-1:200
Immunohistochemistry Frozen (IHF) 1:50-1:200
Immunoprecipitation (IP) 1:20-1:50
Flow Cytometry 1:20-1:100

Properties
Form Liquid
Storage Buffer Supplied in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol.
Storage Instructions Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed.
Purification Affinity-chromatography
Isotype Rabbit IgG
Clonality Monoclonal

Examples
  • CDKN2A Antibody, MAb, Rabbit
    • CDKN2A Antibody, MAb, Rabbit

    All lanes use CDKN2A Antibody, mAb, Rabbit at 1:1K dilution for 1 hour at room temperature.


Background
Target Background Acts as a negative regulator of the proliferation of normal cells by interacting strongly with CDK4 and CDK6. This inhibits their ability to interact with cyclins D and to phosphorylate the retinoblastoma protein.
Synonyms CDKN2A; CDKN2; MTS1; isoforms 1/2/3; Cyclin-dependent kinase 4 inhibitor A; CDK4I; P16INK4; p16INK4a; Multiple tumor suppressor 1;

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.